Elon Musk's brain-chip company Neuralink is set to implant its revolutionary Blindsight chip on its first human patient in ...

Elon Musks Neuralink is set to revolutionize vision restoration with its groundbreaking Blindsight technology, aimed at ...

Neuralink's Blindsight chip, set for human trials in 2025, aims to restore vision for the blind by directly stimulating the ...

The US Food and Drug Administration (FDA) granted Blindsight a ‘breakthrough’ status last year in September. This tag is ...

Blindsight received ‘breakthrough’ status from the US Food and Drug Administration (FDA) in September last year. It has been ...

Neuralink received a US FDA approval for the Blindsight chip in September 2024. It was designated as a ‘breakthrough device’.

Elon Musk has said that the first person to receive the Blindsight version of Neuralink will be treated this year.

According to Musk, Blindsight is designed to allow those who have lost both eyes and their optic nerve to see and even enable ...

Elon Musk's startup, Neuralink, plans to implant its artificial visual prosthesis, 'Blindsight', in a human for the first time by late 2025.

Neuralink is now developing a brain chip that will help blind people see again. Musk recently announced that it is known as Blindsight and will be implanted into a human for the first time this year.